We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+5.67%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.78B
AUM Growth
–
Cap. Flow
+$4.65B
Cap. Flow
% of AUM
97.21%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
616
New
605
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$91.9M |
| 2 |
CELG
Celgene Corp
CELG
|
+$79.7M |
| 3 |
Apple
AAPL
|
+$78.2M |
| 4 |
Qualcomm
QCOM
|
+$73.5M |
| 5 |
Amgen
AMGN
|
+$71.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.38% |
| 2 | Financials | 14.02% |
| 3 | Technology | 12.7% |
| 4 | Industrials | 8.01% |
| 5 | Energy | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Kimberly-Clark
KMB
$36.4B
| $1.87M | 0.04% |
+16,172
| New | +$1.79M |
|
|
EGN
352
DELISTED
Energen
EGN
| $1.87M | 0.04% |
+29,278
| New | +$1.85M |
|
353
Humana
HUM
$46.7B
| $1.86M | 0.04% |
+12,958
| New | +$1.77M |
|
|
CERN
354
DELISTED
Cerner Corp
CERN
| $1.86M | 0.04% |
+28,781
| New | +$1.79M |
|
|
RLYP
355
DELISTED
RELYPSA INC COM
RLYP
| $1.85M | 0.04% |
+60,000
| New | +$1.43M |
|
|
HSP
356
DELISTED
HOSPIRA INC
HSP
| $1.84M | 0.04% |
+30,017
| New | +$1.69M |
|
357
Kroger
KR
$34.8B
| $1.83M | 0.04% |
+56,900
| New | +$1.65M |
|
|
SGMO
358
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.82M | 0.04% |
+120,000
| New | +$1.46M |
|
|
DRNA
359
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.81M | 0.04% |
+110,000
| New | +$1.27M |
|
|
SNI
360
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $1.79M | 0.04% |
+23,758
| New | +$1.81M |
|
361
Enanta Pharmaceuticals
ENTA
$372M
| $1.78M | 0.04% |
+35,000
| New | +$1.57M |
|
362
Telus
TU
$16B
| $1.77M | 0.04% |
+97,754
| New | +$1.76M |
|
363
Applied Materials
AMAT
$426B
| $1.76M | 0.04% |
+70,499
| New | +$1.59M |
|
364
Capital One
COF
$124B
| $1.75M | 0.04% |
+21,168
| New | +$1.72M |
|
|
LVLT
365
DELISTED
Level 3 Communications Inc
LVLT
| $1.74M | 0.04% |
+35,141
| New | +$1.62M |
|
366
Baidu
BIDU
$35.8B
| $1.72M | 0.04% |
+7,535
| New | +$1.73M |
|
|
MR
367
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
| $1.72M | 0.04% |
+65,000
| New | +$1.9M |
|
|
LDRH
368
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $1.71M | 0.04% |
+52,000
| New | +$1.71M |
|
|
CBIO
369
Crescent Biopharma
CBIO
$602M
| $1.69M | 0.04% |
+2,350
| New | +$1.84M |
|
370
Bank of Montreal
BMO
$125B
| $1.69M | 0.04% |
+23,788
| New | +$1.7M |
|
|
AEGR
371
DELISTED
Aegerion Pharmaceuticals
AEGR
| $1.68M | 0.04% |
+80,000
| New | +$2.02M |
|
372
Intuitive Surgical
ISRG
$121B
| $1.67M | 0.03% |
+28,368
| New | +$1.58M |
|
|
RAI
373
DELISTED
Reynolds American Inc
RAI
| $1.65M | 0.03% |
+51,432
| New | +$1.63M |
|
374
General Mills
GIS
$19.2B
| $1.65M | 0.03% |
+30,870
| New | +$1.6M |
|
375
Waste Management
WM
$95.9B
| $1.63M | 0.03% |
+31,774
| New | +$1.55M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Candriam SCA, which disclosed 616 positions worth $4.78B. Its ten largest holdings account for 14% of the portfolio.
Its largest position is Gilead Sciences: 888,125 shares worth $83.7M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Financials and Technology.
- Candriam SCA's largest Q4 2014 buy was Gilead Sciences: 888,125 shares worth $83.7M.
- Candriam SCA's ten largest holdings make up 14% of its $4.78B portfolio in Q4 2014.
- Candriam SCA disclosed 616 positions in Q4 2014, its first 13F filing on record.
Based on Candriam SCA's 13F filing for Q4 2014, filed 26 Mar 2015.